Regulatory & Administrative Law

The pharmaceutical landscape is currently defined by a high-stakes tug-of-war as the administration seeks to solidify temporary, voluntary drug pricing agreements into rigid federal laws that would permanently reshape Medicare’s financial framework. This push aims to incorporate "most-favored

The shift from being a relentless corporate watchdog to a high-ranking federal strategist has placed Robert F. Kennedy Jr. in an unprecedented crossfire between national policy and grassroots expectations. For years, the "Make America Healthy Again" (MAHA) movement operated on the belief that

Desiree Sainthrope is a distinguished legal expert with extensive experience in navigating the intersection of federal law, international trade, and emerging technology. Her deep background in drafting complex compliance frameworks and analyzing aviation safety directives has made her a

A profound disconnect has emerged between the federal government’s fiscal policies and the surging cultural demand for a decentralized, nutrition-focused approach to American healthcare. The "One Big Beautiful Bill Act" introduced rigid federal student loan caps, creating a financial divide between

Standing at the pharmacy counter often feels like a gamble where the house always wins, regardless of how many insurance cards a patient carries in their wallet. While most Americans focus on the pharmaceutical companies that manufacture medication, a trillion-dollar industry of intermediaries

The hum of high-density server racks now echoes through the valleys of the Susquehanna, signaling a transformation that promises immense wealth while simultaneously threatening the monthly budgets of millions of Pennsylvania households. This digital expansion represents a defining moment for the